FDBusiness.com

Nestlé Institute of Health Sciences to Develop New Test For Early Alzheimer’s Disease

 Breaking News
  • Vion Names New CEO Vion, the international meat group, has appointed Ronald Lotgerink as its new CEO with effect from 1 September. Ronald Lotgerink is currently the CEO of Zwanenberg Food Group, a leading European producer and exporter of meat products, canned meat, snacks, soups and sauces. Ronald Lotgerink started his career at KPMG. In 1989 he joined Zwanenberg Food [...]...
  • Harrogate Water Reports Record Sales Harrogate Water has announced another year of record sales with growth of 24 per cent – almost four times higher than market growth for bottled water. The company has seen increased sales in the high-volume supermarket sector, continued strong growth in export and travel markets and greater demand for premium glass products in both grocery [...]...
  • Alcohol Worth £16 Billion is UK’s Leading FMCG Category Innovation in the drinks sector and a reduction in the amount of trade promotions has seen Alcohol retain its place as the top selling FMCG category in the UK, worth £16.1 billion (€18.2 billion) in value sales to the economy. This is according to big data and technology expert for consumer industries, IRI’s Top Categories Special Report – an analysis [...]...
  • Irish Grocery Market Fends Off the Beast from the East The latest grocery market share figures from Kantar Worldpanel, published today for the 12 weeks ending 25 March 2018, show that the Irish grocery market brushed off the Beast from the East to post strong sales growth of 3.8%. Douglas Faughnan, consumer insight director at Kantar Worldpanel, comments: “Although shoppers had upped their spend in preparation for [...]...
  • TrayTrack – A Unique Inline Overhead Concept For Optimum Tray Logistics Once trays have been filled with product, poultry processors will often be faced with how to transport them to packaging equipment elsewhere in the plant. This job can be done manually using crates. Alternatively, product can be transported on a complex system of belt conveyors, usually criss-crossing other similar systems. TrayTrack, a unique automated solution [...]...

Nestlé Institute of Health Sciences to Develop New Test For Early Alzheimer’s Disease

Nestlé Institute of Health Sciences to Develop New Test For Early Alzheimer’s Disease
September 28
10:15 2015

The Nestlé Institute of Health Sciences SA (NIHS), a fundamental research institute of the global nutrition, health and wellness company Nestlé, has signed a research collaboration agreement with AC Immune SA – a leading Lausanne-based biopharmaceutical company focused on neurodegenerative diseases. The aim of the collaboration is to develop a sensitive, minimally invasive Tau diagnostic assay for early Alzheimer’s disease (AD) by applying Nestlé’s proprietary multiplexed ultrasensitive antibody technology platform.

Tangles of Tau proteins are recognised as one of two major hallmarks of neurodegeneration, the other being beta-amyloid (Abeta) plaques. Tangles and other abnormal forms of Tau protein accumulate inside the brain cells and spread between cells of people with Alzheimer’s disease over a long period of time. It is now well established that Tau correlates well with cognitive decline and disease progression. Furthermore, Tau may develop into a suitable biomarker for early diagnosis of the disease.

“This collaboration agreement opens up exciting new possibilities in the quest to better understand and combat this debilitating disease,” comments Ed Baetge, Head of NIHS. “By bringing together our ultrasensitive next-generation diagnostic platform and AC Immune’s expertise in the field, we hope to develop a minimally invasive Tau diagnostic using patients’ blood which can identify Alzheimer’s patients at a very early, and potentially pre-symptomatic, stage of the disease.”

Andrea Pfeifer, CEO of AC Immune, comments: “The development of a minimally invasive diagnostic test to identify patients at very early stages is considered as one of the most pressing needs in the treatment of Alzheimer’s disease.”

Ed Baetge adds: “Our overarching goal at NIHS is to develop nutritional approaches and technologies that help people maintain or improve their cognitive vigour especially for early diagnosis and targeted intervention to combat this global health problem.”

Nestlé’s technology is a patented diagnostic antibody-based platform capable of measuring soluble proteins with high sensitivity and specificity. The technology was developed by Prometheus Laboratories In., a Nestlé Health Science company. Since 2013, NIHS has applied it in Brain Health research, specifically in Alzheimer’s. The assay uses a triplex antibody microarray-based platform that measures the expression and activation of target proteins in tissues, blood or other fluids.

About Author

mike

mike

Related Articles



Food & Drink Business Conference & Exhibition 2016

Upcoming Events

  • April 19, 2018Expo Drink & Wine
  • April 19, 2018GastroPan Exhibition
  • April 22, 2018Natural & Organic Products 
  • April 24, 2018Seafood Processing Global
AEC v1.0.4

find food jobs

The Magazine

F&D Business Preferred Suppliers

New Subscriber





Subscribe Here



Advertisements